Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats

Hepatobiliary and Pancreatic Diseases International

Volumn 2, Issue 3, 2003, Pages 391-396

  Wang, Hai ^a   Chen, Xiao Ping ^a   Qiu, Fa Zu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Hepatic cirrhosis; Nitric oxide synthase message; Pathogenesis; Portal hemodynamics; Ribonuleic acid; Salviae miltiorrhizae

Indexed keywords

CARBON TETRACHLORIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SALVIA MILTIORRHIZA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CIRCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HEMODYNAMICS; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

ANIMALS; CARBON TETRACHLORIDE; DRUGS, CHINESE HERBAL; HYPERTENSION, PORTAL; LIVER; LIVER CIRCULATION; LIVER CIRRHOSIS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; PLANT EXTRACTS; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0042913094     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Earley S, Walker BR. Increased nitric oxide production following chronic hypoxia contributes to attenuated systemic vasoconstriction. Am J Physiol Heart Circ Physiol 2003;284:H1655-1661.
2. Chiva M, Soriano G, Rochat I, et al. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002;37:456.
3. Cappellesso S, Thibault G, Hoarau C, et al. FasL-transfected endothelial cells decrease the proliferative response of allogeneic PBL. Transpl Immunol 2002; 10:293-302.
4. Cardenas A, Bataller R, Arroyo V. Mechanisms of ascites formation. Clin Liver Dis 2000;4:447-465.
5. Lefilliatre P, Sogni P, Bertrand V, et al. Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor. J Gastroenterol Hepatol 2001;16:70-78.
6. Liu YL, Li DC, Lu HM, et al. The control to 3T6 fibroblast from four calcium antagonist. J Peking Med 1996;18:26-29.
7. Wang BE, Sun S, Bai N, et al. The therapeutic observation to experimental liver fibrosis of the active and decongestive Chinese medicine. Chin Med Herb 1990; 21;23.
8. Fan LY, Kong XT, Gao CF, et al. The effects of DNA and collagen synthesis to rat liver cell and pit cell. Chin J Dig 1994;14:339-342.
9. Barbaric D, Dalla-Pozza L, Byrne JA. A reliable method for total RNA extraction from frozen human bone marrow samples taken at diagnosis of acute leukaemia. J Clin Pathol 2002;55:865-867.
10. Kim S, Ponka P. Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis. Proc Natl Acad Sci USA 2002;99:12214-12219.
11. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15: 323-350.
12. Norimatsu M, Harris J, Chance V, et al. Differential response of bovine monocyte-derived macrophages and dendritic cells to infection with Salmonella typhimurium in a low-dose model in vitro. Immunology 2003; 108:55-61.
13. Martin PY, Bianchi M, Roger F, et al. Arginine vasopressin modulates expression of neuronal NOS in rat renal medulla. Am J Physiol Renal Physiol 2002;283: F559-568.
14. Murthy KS, Teng B, Jin J, et al. G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor. Am J Physiol 1998 ;275 (6 Pt 1): C1409-1416.
15. Frey A, Schneider-Rasp S, Marienfeld U, et al. Biochemical and functional characterization of nitric oxide synthase III gene transfer using a replication-deficient adenoviral vector. Biochem Pharmacol 1999;58:1155-1166.